Osteoclasts- What Do They Do and How Do They Do It? Prof. Steven L. Teitelbaum

Similar documents
Deposition of Bone by the Osteoblasts. Bone is continually being deposited by osteoblasts, and it is continually being resorbed where osteoclasts are

Osteoporosis and its Association with Rheumatoid Arthritis and Prednisolone Therapy

silent epidemic,. (WHO),

Glucocorticoids suppress bone formation via the osteoclast

Mechanisms Underlying the Regulation and Functions of HDAC7 in Osteoclast Differentiation

Clinical Biochemistry

ELUCIDATING THE ROLE OF INTEGRIN-EXTRACELLULAR MATRIX PROTEIN INTERACTIONS IN REGULATING OSTEOCLAST ACTIVITY

Regulation of Osteoclast Differentiation

Comment les cellules osseuses communiquent entre elles. Gérard Friedlander Journées UPA 2011

HHS Public Access Author manuscript Nat Rev Rheumatol. Author manuscript; available in PMC 2015 September 01.

DISEASES WITH ABNORMAL MATRIX

Osteoclast: Origin and Differentiation

Osteoclast Culture Kit

IL-17 in health and disease. March 2014 PSO13-C051n

THE ROLE OF CHOLINE KINASE BETA IN BONE HOMEOSTASIS

CHAPTER 2. Literature Review. Bone Homeostasis. 2.1 Introduction. 2.2 Composition of bone

3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions

Osteoclast Culture Kit

Siglec-15 Is A Potential Therapeutic Target For Postmenopausal Osteoporosis

Generation of post-germinal centre myeloma plasma B cell.

The role of IL-17A in postmenopausal inflammatory events, such as in osteoporosis

Silent Killer: Osteoporosis

Mutation in Osteoactivin Enhances RANKL-Mediated Signaling, Promoting Osteoclast Differentiation, Survival and Inhibiting Bone Resorption

The Regulation of Cathepsin K Gene Expression

The Pathogenesis of Bone Erosions in RA FULL VERSION

ANATOMY AND ULTRASTRUCTURE OF BONE HISTOGENESIS, GROWTH AND REMODELING

New Agents for Myeloma Bone Disease

The Phagocytic Synapse in Distinguishing Particulate and Soluble Stimuli David M. Underhill

RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis

Philip Osdoby 1,2. Metabolism, Washington University Medical School, St. Louis, MO 63110, and 3 Department of

M-CSF mediates TNF-induced inflammatory osteolysis

Bone and Cancer. Peter Croucher

Bone Cell Biology. David W. Dempster, PhD. Professor of Clinical Pathology Columbia University. Bone Remodeling

Bone Cell Biology. The Remodeling Cycle. Bone Remodeling. Remodeling Maintains Mechanical Strength. David W. Dempster, PhD

Differentiation and function of osteoclasts. Takeshi Miyamoto and Toshio Suda

Studies on the phenotype and function of osteoclasts using osteopetrotic and rachitic animal models

C-mpl Expression in Osteoclast Progenitors: A Novel Role for Thrombopoietin in Regulating Osteoclast Development

Rama Nada. - Mousa Al-Abbadi. 1 P a g e

Osteoimmunology: Interplay Between the Immune System and Bone Metabolism

SUPPLEMENTARY INFORMATION

ACID-BASE BALANCE URINE BLOOD AIR

Introduction to Biomedical Engineering: Basic concepts and Bone Biomechanics

Osteoclasts: New Insights

Osteoclast Activity Assay Substrate

Assessment and Treatment of Osteoporosis Professor T.Masud

The Calcitonin Gene Family of Peptides: Receptor Expression and Effects on Bone Cells

3/19/2009. The task of the kidney in acid-base balance Excretion of the daily acid load. Buffering of an acid load. A o B - + H + B - A o +OH - C +

Bone metastases in hematology

Who manipulates who in dysregulated mineralised tissue resorption? Dr Gurå Therese Bergkvist MRCVS

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation

The recruitment of leukocytes and plasma proteins from the blood to sites of infection and tissue injury is called inflammation

PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2

Oral Abstracts 2B (Basic) - Osteoclast formation and function

Species differences in histomorphometry

Review. Interaction between osteoblast and osteoclast: impact in bone disease. Histology and Histopathology

Supplementary data Supplementary Figure 1 Supplementary Figure 2

A KL/R / AN A K/O / P O G G

Talib A. Najjar, DMD, MDS, PhD Professor Oral & Maxillofacial Surgery Rutgers University

Principles of Genetics and Molecular Biology

Osteoporosis - Pathophysiology and diagnosis. Bente L Langdahl Department of Endocrinology Aarhus University Hospital Aarhus, Denmark

M. Neale Weitzmann 1,2. 1. Introduction

Osteoclasts, macrophages, and the molecular mechanisms of bone resorption

DISCLOSURES TOPICS" PATHOPHYSIOLOGY of OSTEOPOROSIS: Pathways That Control Bone Remodeling! Why Do Bones Remodel?" Nothing to disclose

Metabolic Diseases. Nutritional Deficiencies Endocrinopathies In-Born Errors of Metabolism

The Impact of Proinflammatory Cytokynes of Rheumatoid Polyarthritis on the Generalized Loss of Bone Mass

BIOLOGY and BIOMECHANICS OF NORMAL & OSTEOPOROTIC BONE

Chapter 3. Osteoclast Biology and Bone Resorption

TITLE: Crosstalk Between Cancer Cells and Bones Via the Hedgehog Pathway Determines Bone Metastasis of Breast Cancer

From Fragile to Firm. Monika Starosta MD. Advocate Medical Group

The ubiquitin-proteasome system. in bone biology. University of Nottingham. ECTS PhD Training July 5 th Dr Rob Layfield

Original Article Eleutherococcus senticosus Inhibits RANKL-induced osteoclast formation by attenuating the NF-κB and MAPKs signaling pathway

THE GROWING GAP IN OSTEOPOROSIS TREATMENT

Seeds and soil theory by Stephen Paget at the end of the XIX century.

JBC Papers in Press. Published on February 14, 2008 as Manuscript M

UMEÅ UNIVERSITY ODONTOLOGICAL DISSERTATIONS New Series No. 91 ISSN ISBN Emma Persson

CONTRACTING ORGANIZATION: Beth Israel Deaconess Medical Center Boston, MA 02115

Repositioning Potential of PAK4 to Osteoclastic Bone Resorption

Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization

Histone Deacetylase 3 and Histone Deacetylase 7 Have. Opposite Effects on Osteoclast Differentiation

regulation of polarized membrane transport by rab GTPases Peter van der Sluijs;

Osteoporosis, Osteomalasia & rickets. Bone disorders

BONE LABORATORY DEMONSTRATIONS. These demonstrations are found on the bulletin boards outside the MCO Bookstore.

COMMENTARY The cell biology of osteoclast function

Cell Cell Communication

Wiskott-Aldrich Syndrome: a cytoskeleton disease

Effects of Anti RANK ligand Denosumab on Beta Thalassemia induced osteoporosis

Dual effects of baicalin on osteoclast differentiation and bone resorption

Cell Cell Communication

Structure and Activation of the Visual Pigment Rhodopsin

Cell Polarity and Cancer

Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL RANK signaling system

A RANK/TRAF6-DEPENDENT SIGNAL TRANSDUCTION PATHWAY IS ESSENTIAL FOR OSTEOCLAST CYTOSKELETAL ORGANIZATION AND RESORPTIVE FUNCTION

Meeting Report. From December 8 to 11, 2012 at Atlanta, GA, U.S.A

THE ROLE OF SEMINAL VESICLE SECRETION (SVS) 7 PROTEIN IN BONE HOMEOSTASIS

Drugs Affecting Bone. Rosa McCarty PhD. Department of Pharmacology & Therapeutics

El Azzouzi et al., http :// /cgi /content /full /jcb /DC1

Therapeutic approaches in bone pathogeneses: targeting the IKK/NF-κB axis

State of the Art Review

Transcription:

Osteoclasts; What Do They Do 1 Steven L. Teitelbaum, M.D. Wilma and Roswell Messing Professor Department of Pathology and Immunology Washington University School of Medicine OSTEOCLASTS OSTEOBLASTS 2 Osteoclasts 3 1

Osteoporosis 4 Osteoporosis (2) 5 Bone remodeling 6 2

Bone remodeling (2) 7 Annu. Rev. Pathol. Mech. Dis.2008 3: 457 84 Bone remodeling (3) MSC OB atgfβ1 TGFβ1 BONE 8 Nat. Med. 2009 15: 757 Bone remodeling (4) 9 3

Osteoporosis 10 Osteopetrosis (Marble bone disease) 11 12 4

Increased bone mass 13 Clinical forms of osteopetrosis Benign - autosomal dominant Malignant - autosomal recessive 14 Malignant osteopetrosis Autosomal recessive Dense sclerotic skeleton Hematologic abnormalities Neurologic abnormalities Death in infancy or early childhood 15 5

16 17 18 6

19 What is the osteoclast precursor? 20 Hematopoietic Precursor?? 21 Stromal Cell 7

Y-chromosome 22 23 Y-body analysis of osteoclasts and osteoblasts Cell Before Analyzed Transplantation After Transplantation Osteoclasts 2 6 13 18 22 weeks weeks weeks weeks weeks Cells (no.) 20 9 14 8 8 3 Nuclei (no.) 137 45 108 41 42 12 Y bodies (no.) 0 27 60 9 12 8 Male nuclei (%) 0 60 56 22 29 67 Osteoblasts Cells (no.) 75 36 58-30 42 Y bodies (no.) 0 0 0-0 0 Male cells (%) 0 0 0-0 0 Coccia et al., NEJM, 1980 302: 701-708 BONE MATRIX Effector substances Effector substances (Cell interaction) 24 BONE MATRIX BONE MATRIX 8

Osteoclast differentiation Stromal Cell/Osteoblast? Stromal Cell/Osteoblast? Macrophage? Osteoclast 25 Bone 26 Osteoclast differentiation Stromal Cell/Osteoblast OPG RANK LIGAND RANK Macrophage Osteoclast 27 Bone 9

Wild type RANK ligand -/- 28 Stromal Cell/Osteoblast OPG RANKL RANK Macrophage c-fms M-CSF Osteoclast 29 Bone Osteoclasts generated in vitro 30 10

Osteoclastogenic signals RANK c-fms 31 Annu. Rev. Pathol. Mech. Dis.2008 3: 457 84 Molecular mechanisms of osteoclast differentiation and function M-CSF RANKL 32 How does the osteoclast degrade bone? 33 11

Osteoclast H + Bone 34 35 36 12

Molecular mechanisms of osteoclast differentiation and function M-CSF RANKL H + ATPase 37 Carbonic anhydrase Osteoclast H + +HCO C.A. - 3 H 2 O+CO2 H + Bone 38 Family with benign osteopetrosis 39 13

40 Molecular mechanisms of osteoclast differentiation and function M-CSF RANKL C.A.II H + ATPase 41 Cl - Osteoclast H + + HCO 3 - C.A. HCO 3 - H 2 O+CO2 H + Bone 42 14

In the presence of Cl - HCO - 3 Cl - Osteoclast HCO - 3 Cl - H + Bone 43 Cl - /HCO 3- exchange 44 J. Clin. Invest.1989; 83(1): 227 233 Cl - /HCO 3- exchange (2) 45 J. Clin. Invest.1989; 83(1): 227 233 15

46 Molecular mechanisms of osteoclast differentiation and function M-CSF RANKL HCO 3- /Cl - C.A.II H + ATPase 47 HCO 3- Cl - Osteoclast Slc4a2 +/+ Slc4a2 -/- H+ Cl-?? H + Cl - Bone 48 16

49 HCO 3- Cl - Osteoclast H + HCO - 3 Cl - H + Cl - Bone 50 51 17

Molecular mechanisms of osteoclast differentiation and function M-CSF RANKL Cl - CHANNEL HCO 3- /Cl - C.A.II H + ATPase 52 HCl? Bone = mineral + organic matrix 53 HCO 3- Cl - Osteoclast H + HCO - 3 Cl - H + Cl - Bone 54 18

55 Pyknodysostosis 56 Molecular mechanisms of osteoclast differentiation and function M-CSF RANKL CATH. K Cl - CHANNEL HCO3 - /Cl - C.A.II H + ATPase 57 19

HCO 3 - Cl - Osteoclast Cath K H + HCO - 3 Cl - H + Cl - Bone 58 Integrin-matrix attachment 59 Integrin family α 3 Peyers Patch Addressin α 4 α 2 α 1 LM Col I FN Fn alt. Col I Col I Col IV Col IV LM LM β 1 α 5 FN RGD LM FN RGD β 5 α 6 β p β 4 VN RGD BM α v β 6 Osteoclast Integrin FB VWF VN OP BSP1 RGD β 3 β 2 C36I FX FB α IIb FB VWF VN FN RGD ICAM-1 ICAM-2 α X α M α L 60 20

β3-/- mice are osteopetrotic 61 J. Clin. Invest. 2000; 105(4): 433 440 β3-/- mice are osteopetrotic (2) b 3 +/+ b 3 +/- b 3 -/- 62 J. Clin. Invest.2000; 105(4):433 440 Osteoclasts TRAP stain of BMM / ST2 cocultures 63 J. Clin. Invest.2000; 105(4): 433 440 21

Osteoclast cytoskeleton 64 Podosome Vinculin 65 Annu. Rev. Pathol. Mech. Dis.2008 3: 457 84 Actin ring αvβ3 66 Annu. Rev. Pathol. Mech. Dis. 2008 3: 457 84 22

Osteoclast E/M BL BL AR RB AR 67 BL= Basolateral Membrane RB= Ruffled Border AR= Actin Ring Non-polarized H + ATPase in non-attached osteoclast 68 Science245: 855, 1989 Osteoclast polarized H + ATPase (proton pump) 69 Science245: 855, 1989 23

Formation of the ruffled border 70 Synaptotagmins (Syt) mediate vesicle/plasma membrane fusion 71 Does SytVII organize the ruffled border SytVII SZ SZ 72 Bone CTK HCl Dev. Cell 14: 914, 2008 24

SytVII -/- osteoclasts have abnormal ruffled border SytVII +/+ SytVII -/- 73 Dev. Cell 14: 914, 2008 SytVII -/- OCs resorb bone poorly 74 Dev. Cell 14: 914, 2008 Integrin-matrix attachment 75 25

αvβ3 Integrin organizes the osteoclast cytoskeleton αv RGD β3 J. Cell Biol. 176: 877, 2007 Nature Med.11: 284, 2005 J. Immunol.183: 1804, 2009 J. Cell Sci. 123: 2955, 2010 p-y Syk SH2Y Y c-src p-416y ITAM RAC GDP VAV3 p-y RAC GTP 76 Stromal Cell/Osteoblast OPG RANKL RANK Macrophage c-fms M-CSF HCO 3 - Cl - Osteoclast Cath K H + HCO - 3 Cl - 77 H + Cl - Bone Molecular mechanisms of osteoclast differentiation and function PU.1 Therapeutic targets M-CSF MITF NFAT RANKL C-FOS NF-κB SytVII Syk Rac Rab3D TRAF6 C-SRC αvβ3 RANKL H + ATPase HCO3 - /Cl - CATH. K αvβ3 Cl - CHAN C.A.II. 78 26

79 27